What are the challenges in researching CBN due to its less prevalent status compared to THC and CBD?
What are the challenges in researching CBN due to its less prevalent status compared to THC and CBD? Researching CBN presents several challenges due to its less prevalent status compared to THC and CBD, primarily stemming from limited availability and regulatory barriers. The lower concentration of CBN in cannabis products makes it difficult to conduct extensive studies, resulting in a lack of robust clinical data to support its therapeutic potential. Furthermore, regulatory restrictions surrounding cannabis research often focus on more well-known cannabinoids like THC and CBD, making it challenging for researchers to obtain necessary approvals for CBN studies. This limited research landscape hinders the understanding of CBN's pharmacological properties and its potential applications in medicine. Addressing these challenges requires advocacy for expanded research opportunities and increased funding for studies exploring CBN's effects (Brenneisen, 2007).